Pharmaceutical Research and Manufacturers of America v. Sean O'Day, in His Official Capacity as Director of the Oregon Department of Consumer and Business Services
1. Whether a government reporting requirement is subject to intermediate First Amendment scrutiny, and satisfies such scrutiny, so long as it aims to correct "information asymmetries" that are "product-specific."
2. Whether entities that operate in "highly regulated" industries categorically lack reasonable investment-backed expectations in their trade secrets for purposes of the Takings Clause.
Whether a government reporting requirement compelling disclosure of product-specific information, including trade secrets, is subject to intermediate First Amendment scrutiny based solely on correcting information asymmetries, and whether entities in highly regulated industries categorically lack reasonable investment-backed expectations in trade secrets for Takings Clause purposes